Copyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=cytrLatest Financial News for CytRx Corporationen-usSat, 12 Dec 2009 10:52:40 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/external/barrons/rss/SIG=11v9mmh6f/*http%3A//online.barrons.com/article/SB126057463180588029.html?ru=yahoo&mod=yahoobarronsResearch Reports Comments from investment analysts on several companies, each with buy/hold/sell recommendations.yahoo_finance/3590558892Sat, 12 Dec 2009 10:52:40 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091210/20091210005204.html?.v=1yahoo_finance/2415870978Thu, 10 Dec 2009 13:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh89390_2009-12-08_00-05-22_bng56694_newsml&rpc=44&type=marketsNewsyahoo_finance/1879976119Tue, 8 Dec 2009 00:05:22 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091207/20091207005073.html?.v=1LOS ANGELES----CytRx Corporation , a biopharmaceutical company, today announced favorable preliminary results from its Phase 2 STAR-1 registration clinical trial for tamibarotene in the treatment of acute promyelocytic leukemia in patients failing other treatments.yahoo_finance/365674102Mon, 7 Dec 2009 13:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091204/cytr8-k.htmlyahoo_finance/1993478602Fri, 4 Dec 2009 18:07:29 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=1377bh6gg/*http%3A//www.fool.com/investing/high-growth/2009/12/03/behind-the-business-3-questions-for-vical.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/1996949917Thu, 3 Dec 2009 14:55:12 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12s3qvcr5/*http%3A//www.thestreet.com/_yahoo/story/10637652/1/seachange-tenet-early-volume-plays.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/2980161883Thu, 3 Dec 2009 13:37:40 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12hqvpe3v/*http%3A//seekingalpha.com/article/176288-cytrx-corporation-a-solid-rebound-play?source=yahooyahoo_finance/931659607Thu, 3 Dec 2009 08:53:06 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/ud?s=CYTRyahoo_finance/984130255Thu, 3 Dec 2009 06:41:25 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091202/0565006.html?.v=1yahoo_finance/59983960Wed, 2 Dec 2009 16:05:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091202/us_cytrx_arimoclomol.html?.v=3Shares of biopharmaceutical company CytRx Corp. rose in morning trading Wednesday after the Food and Drug Administration lifted a nearly two-year suspension on development of arimoclomol as a treatment for Lou Gehrig's disease.yahoo_finance/801378969Wed, 2 Dec 2009 15:01:56 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh23141_2009-12-02_14-47-37_bng420122_newsml&rpc=44&type=marketsNewsyahoo_finance/2845291973Wed, 2 Dec 2009 14:47:37 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091202/20091202005127.html?.v=1LOS ANGELES----CytRx Corporation , a biopharmaceutical company, is permitted to re-enter the clinic with its orally administered molecular chaperone drug candidate arimoclomol as a therapeutic treatment for amyotrophic lateral sclerosis , following the U.S.yahoo_finance/941860826Wed, 2 Dec 2009 13:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091201/cytr8-k.htmlyahoo_finance/154407297Tue, 1 Dec 2009 17:44:13 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091201/20091201005192.html?.v=1LOS ANGELES----CytRx Corporation , a biopharmaceutical company, continued to broaden its management expertise by naming industry veteran Scott Geyer Senior Vice President of Manufacturing.yahoo_finance/3119842692Tue, 1 Dec 2009 13:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=13360skco/*http%3A//seekingalpha.com/article/175426-cytrx-announces-first-of-two-positive-developments-ahead?source=yahooyahoo_finance/3019513173Thu, 26 Nov 2009 10:17:07 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091124/20091124005116.html?.v=1LOS ANGELES----CytRx Corporation , a biopharmaceutical company, today announced plans to initiate a multinational Phase 2 clinical trial with its doxorubicin prodrug INNO-206 as a treatment for patients with advanced soft tissue sarcomas who have failed surgery and radiation.yahoo_finance/2824719560Tue, 24 Nov 2009 13:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12jq8s9vg/*http%3A//seekingalpha.com/article/175035-cytrx-corporation-key-developments-ahead?source=yahooyahoo_finance/427720627Tue, 24 Nov 2009 13:25:15 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091123/0562051.html?.v=1yahoo_finance/343631025Mon, 23 Nov 2009 15:38:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12c6ne360/*http%3A//seekingalpha.com/article/174834-cytrx-technical-breakout-imminent?source=yahooyahoo_finance/1579246212Mon, 23 Nov 2009 15:19:38 Etc/GMT